Literature DB >> 8339016

Follicle stimulating hormone levels on cycle day 3 predict ovulation stimulation response.

A Ebrahim1, G Rienhardt, S Morris, T F Kruger, C J Lombard, J P Van der Merwe.   

Abstract

AIM: To determine the value of basal follicle stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2) levels on cycle day 3 in predicting the ovulation stimulation response in patients receiving exogenous gonadotropins for in vitro fertilization (IVF) or gamete intrafallopian transfer (GIFT).
METHODS: One hundred eleven consecutive females with infertility due to various etiologies were investigated. Cycle day 3 serum levels of FSH, LH, and E2 were determined prior to ovulation induction with a combination of clomiphene citrate and human gonadotropins. Follicular growth was monitored ultrasonically, and when appropriate, oocytes were recruited, counted, graded, and then used, as prearranged, for either IVF or GIFT. Basal hormone levels were compared to the peak E2 concentration, the number of follicles aspirated, and the number of preovulatory oocytes recovered following drug therapy. Details of resulting pregnancies were also recorded.
RESULTS: Patients with low basal FSH levels (< 11.5 mIu/ml) yielded a higher mean number of preovulatory oocytes than those with high values (> 11.5 mIu/ml), i.e., 6.7 oocytes per cycle vs 2.5 oocytes (P < 0.001). In the low group 97% of cycles yielded more than three fertilizable oocytes compared to 42% in the high group (P < 0.5). There were 16 term pregnancies (16%) in the low group and 1 (8.3%) in the high group. Basal LH and E2 levels did not improve on the ability to distinguish between different populations of infertile females who responded differently to ovulation induction.
CONCLUSION: Cycle day 3 FSH levels are predictive of the ovulation response and probability of pregnancy in stimulated cycles and can be of value in patient selection and counseling in IVF and GIFT programs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339016     DOI: 10.1007/bf01207735

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  22 in total

1.  Characterization and response of women undergoing repeat cycles of ovulation induction in an in vitro fertilization and embryo transfer program.

Authors:  R Lyles; W E Gibbons; M G Dodson; A N Poindexter; R L Young; I K Rossavik; W E Findley
Journal:  Fertil Steril       Date:  1985-12       Impact factor: 7.329

2.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

Authors:  P Serafini; B Stone; J Kerin; J Batzofin; P Quinn; R P Marrs
Journal:  Fertil Steril       Date:  1988-01       Impact factor: 7.329

3.  Corpus luteum function after follicle aspiration for oocyte retrieval.

Authors:  J Garcia; G S Jones; A A Acosta; G L Wright
Journal:  Fertil Steril       Date:  1981-11       Impact factor: 7.329

4.  Oocyte donation in 61 patients.

Authors:  P F Serhal; I L Craft
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

5.  Hormonal characteristics of the human menstrual cycle throughout reproductive life.

Authors:  B M Sherman; S G Korenman
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

6.  [Ovulation induction for in vitro fertilisation at the Tygerberg Hospital].

Authors:  J P van der Merwe; T F Kruger; C J Lombard; L M Muller
Journal:  S Afr Med J       Date:  1987-04-18

7.  Outcome of in vitro fertilization in women with low response to ovarian stimulation.

Authors:  A Pellicer; A Lightman; M P Diamond; J B Russell; A H DeCherney
Journal:  Fertil Steril       Date:  1987-05       Impact factor: 7.329

8.  Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization.

Authors:  J M Jenkins; D W Davies; H Devonport; F W Anthony; S C Gadd; R H Watson; G M Masson
Journal:  Hum Reprod       Date:  1991-08       Impact factor: 6.918

9.  Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations.

Authors:  I T Cameron; F C O'Shea; J M Rolland; E G Hughes; D M de Kretser; D L Healy
Journal:  J Clin Endocrinol Metab       Date:  1988-12       Impact factor: 5.958

10.  Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.

Authors:  K Droesch; S J Muasher; R G Brzyski; G S Jones; S Simonetti; H C Liu; Z Rosenwaks
Journal:  Fertil Steril       Date:  1989-02       Impact factor: 7.329

View more
  3 in total

1.  Confounding variables affecting in vitro fertilization success: a decade of experience.

Authors:  M Alsalili; A A Yuzpe; I S Tummon; J Parker; J S Martin; J A Nisker; S A Daniel
Journal:  J Assist Reprod Genet       Date:  1995-02       Impact factor: 3.412

2.  The predictive value of basal follicle stimulating and growth hormone levels as determined by immunofluorometry during assisted reproduction.

Authors:  C Huyser; F L Fourie; J Pentz; P Hurter
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

3.  ICSI Outcome in Infertile Couples with Different Causes of Infertility: A Cross-Sectional Study.

Authors:  Mahnaz Ashrafi; Shahideh Jahanian Sadatmahalleh; Mohammad Reza Akhoond; Firouzeh Ghaffari; Zahra Zolfaghari
Journal:  Int J Fertil Steril       Date:  2013-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.